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Fast inhibitory neurotransmission in the brain is mediated by wide range of
GABAA receptor (GABAAR) and glycine receptor (GlyR) isoforms, each with different
physiological and pharmacological properties. Because multiple isoforms are expressed
simultaneously in most neurons, it is difficult to define the properties of individual
isoforms under synaptic stimulation conditions in vivo. Although recombinant expression
systems permit the expression of individual isoforms in isolation, they require
exogenous agonist application which cannot mimic the dynamic neurotransmitter
profile characteristic of native synapses. We describe a neuron-HEK293 cell co-
culture technique for generating inhibitory synapses incorporating defined combinations
of GABAAR or GlyR subunits. Primary neuronal cultures, prepared from embryonic
rat cerebral cortex or spinal cord, are used to provide presynaptic GABAergic
and glycinergic terminals, respectively. When the cultures are mature, HEK293 cells
expressing the subunits of interest plus neuroligin 2A are plated onto the neurons,
which rapidly form synapses onto HEK293 cells. Patch clamp electrophysiology is
then used to analyze the physiological and pharmacological properties of the inhibitory
postsynaptic currents mediated by the recombinant receptors. The method is suitable
for investigating the kinetic properties or the effects of drugs on inhibitory postsynaptic
currents mediated by defined GABAAR or GlyR isoforms of interest, the effects of
hereditary disease mutations on the formation and function of both types of synapses,
and synaptogenesis and synaptic clustering mechanisms. The entire cell preparation
procedure takes 2–5 weeks.
Keywords: inhibitory postsynaptic current, IPSC, GABAergic, glycinergic, neuropharmacology, synaptogenesis,
electrophysiology
INTRODUCTION
The central nervous system is comprised of circuits of interconnected neurons that serve to process
speciﬁc types of information. These circuits regulate their own output by feedback and feedforward
connections. Knowledge of the physiological properties of the inhibitory and excitatory synapses
that mediate these connections is crucial for understanding the electrical behavior of circuits and
ultimately of brain function. Fast inhibitory neurotransmission in these circuits is mediated by
GABA type-A receptor (GABAAR) and glycine receptor (GlyR) chloride channels.
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GABAARs exhibit a particularly broad range of heterogeneity.
As members of the pentameric ligand-gated ion channel (pLGIC)
family, ﬁve subunits are required to form a single functional
oligomer. There are 19 GABAAR genes (α1–6, β1–3, γ1–3, δ,
ε, θ, π, and ρ1–3) with the most common synaptic isoform
comprising α1, β2, and γ2 subunits in a 2:2:1 stoichiometry.
Although many hundreds of other subunit combinations are
theoretically possible, it is thought that around one hundred exist
naturally in the brain (Olsen and Sieghart, 2009). GlyRs exhibit
far less diversity with only four genes (α1–3, β) in humans (Lynch,
2009). They also belong to the pLGIC family and synaptic GlyR
isoforms comprise heteromeric assemblies of α and β subunits in
a 2:3 or 3:2 stoichiometry (Durisic et al., 2012; Yang et al., 2012).
Each GABAAR or GlyR isoform has a unique physiological
and pharmacological proﬁle and it is the unique properties
of a particular isoform that are important for the appropriate
functioning of a particular network. Disruptions to these
properties can result in neurological disorders. For example,
hereditary mutations that aﬀect the function of GABAARs
or GlyRs can lead to epilepsy (Macdonald et al., 2010) or
human hyperekplexia (Bode and Lynch, 2014), respectively.
Other disruptive mechanisms are also possible. For example, a
post-transcriptional RNA editing mechanism that is upregulated
in temporal lobe epilepsy increases the prevalence of α3
GlyRs incorporating the P185L mutation (Meier et al., 2005;
Eichler et al., 2008, 2009). Finally, a range of neurological
disorders is known to result from aberrant changes to pLGIC
phosphorylation status (Talwar and Lynch, 2014). For example,
chronic pain sensitization is caused by prostaglandin-induced
phosphorylation of α3 GlyRs (Harvey et al., 2004; Zeilhofer, 2005;
Lynch and Callister, 2006) and ethanol-induced phosphorylation
of the γ2 GABAAR subunit contributes to alcoholism (Qi et al.,
2007).
Thus, characterizing the physiological and pharmacological
properties of deﬁned GABAAR and GlyR isoforms under
synaptic activation conditions is essential for understanding how
neuronal circuits function in health and disease. However, it is
diﬃcult to study individual isoforms in their native neuronal
environment due to the multitude of other isoforms present,
and the diﬃculty in pharmacologically or genetically isolating the
receptor isoform of interest. The neuron-HEK293 cell co-culture
protocols we describe here solve this problem by providing a
simple, eﬃcient means of generating functional recombinant
inhibitory synapses that selectively incorporate the recombinant
GABAAR or GlyR isoform of interest.
Co-culture approaches have previously been developed to
understand the roles of synaptic adhesion molecules (including
neurexin and neuroligin) in the formation of glutamatergic or
GABAergic synapses (Scheiﬀele et al., 2000; Biederer et al., 2002;
Dean et al., 2003; Graf et al., 2004; Sara et al., 2005; Kim et al.,
2006; Dong et al., 2007; Fuchs et al., 2013) or to investigate the
impact of disease-causing neuroligin mutations on GABAergic
synaptogenesis (Chubykin et al., 2005; Sun et al., 2011). They
have also been employed to characterize the functional properties
of inhibitory post-synaptic currents (IPSCs), and have revealed
kinetic diﬀerences among diﬀerent GABAAR isoforms (Wu et al.,
2012; Dixon et al., 2014) and GlyR isoforms (Zhang et al., 2014).
The original co-culture protocol, involving postnatal
hippocampal neurons and transfected HEK293 cells,
was optimized for the immunohistochemical analysis of
glutamatergic and GABAergic synapse development (Biederer
and Scheiﬀele, 2007). A more recent protocol outlined an
improved procedure for generating recombinant GABAergic
synapses between striatal medium spiny GABAergic neurons
and transfected HEK293 cells (Brown et al., 2014). However, this
was also optimized for monitoring synapse development rather
than for recording IPSCs in mature synapses. We have extended
the co-culture approach in three ways. First, we describe the
ﬁrst spinal neuron-HEK293 cell co-culture preparation suitable
for the eﬃcient generation of recombinant glycinergic synapses.
Second, we have simpliﬁed the technique for creating GABAergic
synapses by using embryonic cortical neurons grown in serum-
free media that does not promote the growth of glia (Brewer et al.,
1993; Brewer, 1995). We have also have optimized the technique
to facilitate the electrophysiological analysis of GABAergic and
glycinergic IPSCs.
MATERIALS AND METHODS
Overview
Protocols for all procedures described in this study are
detailed in the Supplementary Information. Lists of reagents
and equipment are also provided. An overview of the co-
culture procedure is presented in Figure 1. The cerebral
cortex contains large populations of GABAergic interneurons
that were used to provide presynaptic GABAergic terminals
onto HEK293 cells that recombinantly express the GABAAR
subunits of interest. Similarly, spinal neurons contain large
populations of glycinergic interneurons that were used to provide
glycinergic presynaptic terminals onto HEK293 cells expressing
GlyR subunits of interest. The main steps in preparing the
neuronal cultures are summarized in Figure 1 (blue box). The
steps involved in HEK293 cell transfection are also described
in Figure 1 (green box). An image of a GABAergic neuron
forming synaptic contacts with HEK293 cell is shown in the
inset.
Preparation of Neuron Cultures
Euthanasia of timed-pregnant rats was performed via CO2
inhalation, in accordance with procedures approved by the
University of Queensland Animal Ethics Committee. To produce
GABAergic interneuron cultures, E18 rat embryos were surgically
removed from timed-pregnant rats and placed into chilled Ca-
Mg-free Hank’s Balanced Salt Solution (CMF-HBSS) under sterile
conditions. The cortical neuronal tissue was then pinched oﬀ
using ﬁne forceps, taking care to peel away the meninges to
keep glial cell numbers down. The dissected neurons were then
triturated, centrifuged and resuspended in Dulbecco’s Modiﬁed
Eagles Medium supplemented with 10% fetal bovine serum
(DMEM-FBS). To produce glycinergic interneuron cultures, E15
rat embryos were surgically removed and placed into ice cold
CMF-HBSS under sterile conditions. The spinal cords were
then removed and pinned at the wider proximal end while
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FIGURE 1 | Overview of the co-culture method. The blue box describes the steps involved in preparing neuronal cultures (GABAergic in upper row, glycinergic in
lower row). The green box describes the steps involved in transfecting HEK293 cells. Inset shows HEK293 cells labeled with a neuroligin-HA antibody (magenta),
surrounded by GABAergic neurons forming synapses (as shown by GAD65 labeling in green).
meninges were carefully detached. The dissected neurons were
then triturated, centrifuged and resuspended in DMEM-FBS.
In both cases, the cells were then counted and between 40,000
and 80,000 neurons were plated onto each 12 mm poly-D-
lysine-coated coverslip in four-well plates. As previously noted,
neuronal density is a key consideration: if it is too low it impairs
neuronal survival and if it is too high it encourages neuron
clumping (Fuchs et al., 2013). Neuronal cultures were always
maintained in a 5% CO2 incubator at 37◦C. After 24 h the entire
DMEM-FBS medium was replaced with Neurobasal medium
including 2% B27 and 1% GlutaMAX supplements. A second
(and ﬁnal) feed 1 week later replaced half of this medium. In
contrast to a previous protocol (Fuchs et al., 2013), we found
that antibiotics were unnecessary. Neurons were used in co-
culture experiments between 3 and 6 weeks later (for GABAergic
co-cultures) or 1–4 weeks later (for glycinergic co-cultures).
Culture and Transfection of HEK293 Cells
HEK293 cells were cultured in T75 ﬂasks in DMEM-FBS and
maintained in a 5% CO2 incubator at 37◦C. The cells were
passaged weekly. Prior to transfection, they were trypsinized and
plated onto 35 mm culture dishes at a density of 5000 cells/dish.
Following overnight incubation, the cells were transfected via a
calcium phosphate co-precipitation protocol, using a total of 0.5–
2.5 μg DNA per dish. Then, following incubation for 5–20 h in a
3% CO2 incubator, the transfection was terminated by washing
twice with divalent cation-free phosphate buﬀered saline. The
cells were then trypsinized, centrifuged, and resuspended in
Neurobasal medium (including 2% B27 and 1% GlutaMAX
supplements) then seeded onto the neurons. One 35 mm dish of
HEK293 cells was suﬃcient to seed four coverslips of neurons.
Once seeded with HEK293 cells, the co-cultures were returned to
the incubator overnight to allow synapses to form. Cultures were
used for patch clamp recording over the following 2–3 days.
Plasmid DNA
A total of 0.5–2.5 μg plasmid DNA should be added to each
35 mm dish of HEK293 cells. This amount may vary according
to the individual plasmid expression eﬃciency, the number and
ratios of plasmids to be transfected and the transfection method.
When using a calcium phosphate co-precipitation protocol,
our recommendations are as follows. When expressing synaptic
GlyRs, the total plasmid DNA should comprise: 0.2μg neuroligin
2A, 0.2μg gephyrin, 0.1μg EGFP, with the remainder comprising
GlyR subunit DNA that varies according to the number of
subunits and the ratio of subunit DNA required. For example,
when transfecting GlyR α subunits as homomers, add 0.5 μg
DNA. When transfecting α and β GlyR subunits in 1:10 or 1:50
ratios add a total of 2μg DNA.We recommend transfecting α1:β,
α2:β, and α3:β subunits in 1:50, 1:50, and 1:10 ratios, respectively
(Zhang et al., 2014). When expressing α1β2γ2 GABAARs, the
α1, β2, γ2, EGFP and neuroligin 2A plasmid DNAs should be
transfected in a 1:1:4:1:1 ratio with a combined total of 0.5 μg
DNA.
In experiments described in Figures 2 and 3 we employed
plasmid DNAs encoding the human α1 (pCIS), rat α3L
(pcDNA3.1), and human β (pcDNA3.1) GlyR subunits, plus
mouse neuroligin 2A (pNice) and rat gephyrin (pCIS). In
experiments described in Figure 4, we employed human α2
(pcDNA3.1), human α4 (pCIS), β2 (pcDNA3.1), and γ2L
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FIGURE 2 | Comparison of the properties of spontaneous glycinergic inhibitory post-synaptic currents (IPSCs) mediated by α1β GlyRs (in black) and
α1A288Gβ GlyRs (in pink). (A) Sample voltage-clamp recordings at three different time scales for both isoforms. (B) Mean IPSC waveforms, each averaged from
>200 events from a single cell. (C) Mean values and distribution histograms for the peak amplitudes, 10–90% rise times and decay time constants of IPSCs
recorded from α1β and α1A288Gβ GlyRs. n.s. = not significant, ∗∗∗∗p < 0.0001 relative to α1β GlyRs.
(pcDNA3.1) GABAAR subunits. Site-directed mutagenesis was
performed using the QuikChange mutagenesis kit (Agilent
Technologies) according to manufacturers’ instructions and the
successful incorporation of mutations was conﬁrmed by DNA
sequencing.
Patch Clamp Electrophysiology and Data
Analysis
Standard patch-clamp electrophysiology equipment can be
used, with the only speciﬁc requirement being a ﬂuorescence
microscope for identifying GFP ﬂuorescent cells. Coverslips
containing the co-cultured cells were placed gently into the
recording chamber on the microscope stage and perfused
continuously with an extracellular solution comprising (in mM):
140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 D-glucose,
adjusted to pH 7.4 with NaOH. Patch pipettes were ﬁlled with
an intracellular solution containing (in mM): 145 CsCl, 2 CaCl2,
2 MgCl2, 10 HEPES, 10 EGTA, and 2 MgATP, adjusted to pH
7.4 with NaOH. HEK293 cell selection is largely a matter of
trial and error. A good starting point is to select large, strongly
ﬂuorescent green cells that are closely surrounded by many
neurons, especially small clumps of neurons. Cells with a textured
(rather than smooth) appearance often yield abundant IPSCs.
The electrophysiological techniques may vary according to the
experimental requirements. For example, if precise quantitation
of rise times is required, it is extremely important that the ﬁltering
and digitisation rates are high and that pipette series resistance is
low to avoid artefactually slowing down the event. In contrast,
testing the eﬀect of a drug on IPSC decay rate is less sensitive
to ﬁltering, and it may be necessary to use higher resistance
pipettes to obtain a membrane seal that is stable enough to permit
recordings that are long enough to apply and wash out the drug.
In all experiments described below, series resistance
was compensated to 60% of maximum and was monitored
throughout the recording. Spontaneous and action potential-
evoked IPSCs in HEK293 cells were recorded at a holding
potential −60 mV and currents were ﬁltered at 4 kHz and
sampled at 10 kHz. Only cells with a stable series resistance
of <25 M throughout the recording period were included
in the analysis. Patch pipettes (4–8 M resistance) were made
from borosilicate glass (GC150F-7.5, Harvard Apparatus).
Analyses of IPSC amplitude, 10–90% rise time, and decay
time constant (single-exponential) were performed using
Axograph × (Axograph Scientiﬁc). Single peak IPSCs with
amplitudes of at least three times above the background
noise were detected using a semi-automated sliding template.
Each detected event was visually inspected and only well-
separated IPSCs with no inﬂections in the rising or decay
phases (suggestive of superimposed events) were included. The
respective parameters from all selected events from a single
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FIGURE 3 | Comparison of the properties of spontaneous glycinergic IPSCs mediated by α3β GlyRs (in black) and α3P185Lβ GlyRs (in blue). (A) Sample
voltage-clamp recordings at three different time scales for both isoforms. (B) Mean IPSC waveforms, each averaged from >200 events from a single cell. (C) Mean
values and distribution histograms for the peak amplitudes, 10–90% rise times and decay time constants of IPSCs recorded from α1β and α3P185Lβ GlyRs.
∗p < 0.05, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 relative to α3β GlyRs.
cell were averaged and are presented as a single data point in
Figures 2–4. The averages from multiple cells were then pooled
to obtain group data. Statistical analysis and plotting were
performed on group data with Prism 5 (GraphPad Software).
All data are presented as mean ± SEM. One-way and two-way
ANOVA were employed for multiple comparisons. For all tests,
the number of asterisks corresponds to level of signiﬁcance:
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001.
RESULTS
Glycinergic IPSCs
While we found that some co-cultures exhibited spontaneous
activity in almost all green ﬂuorescent HEK293 cells, it was more
typical to observe spontaneous glycinergic IPSCs in around 20%
of cells. This success rate is adequate for most experiments.
It is important to establish that the spontaneous IPSCs
produced by the co-culture synapses exhibit similar
characteristics to those mediated by native synapses
incorporating the same subunits. Figure 2A shows sample
IPSC recordings from HEK293 cells expressing α1β GlyRs. An
IPSC averaged from >200 events recorded from multiple cells is
shown in Figure 2B. Mean amplitudes, 10–90% rise times and
decay time constants are presented in Figure 2C. Frequency
distributions of IPSC amplitudes, 10–90% rise times and decay
time constants all exhibit monotonic distributions suggesting
a single functional population of synapses (Figure 2C). In
adult hypoglossal motor neurons, where the α1β GlyR isoform
predominates (Lynch, 2009), the 10–90% rise times and
decay time constants range between 0.6–1.8 and 4.9–7.7 ms,
respectively (Singer et al., 1998; Graham et al., 2006; Hirzel et al.,
2006; Muller et al., 2006). The mean decay time constant (9.3 ms)
and the 10–90% rise time (1.9 ms) recorded in our co-culture
synapses correspond well with these results.
We performed a similar analysis on α3β co-culture synapses
and found the mean IPSC rise and decay times to be remarkably
similar to those mediated by α1β GlyRs (Figures 3A–C). These
parameters were also distributed monotonically, again suggesting
a single population of synapses (Figure 3C). Although α3β-
mediated IPSCs have yet to be recorded in isolation in native
neurons, evidence to date suggests their rise and decay times
are indistinguishable from those mediated by α1β GlyRs (Harvey
et al., 2004). This ﬁts well with the results from our engineered
synapses.
The α1 GlyR subunit D80A and A52S mutations result
in startle disease phenotypes in mice (Graham et al., 2006;
Hirzel et al., 2006). We previously demonstrated that engineered
synapses incorporating α1D80Aβ and α1A52Sβ GlyRs exhibited
accelerated IPSC decay rates closely resembling those recorded
in native synapses from mutant mice homozygous for these
mutations (Zhang et al., 2014). This provides an important
validation of our technique. In this study we sought to
determine whether GlyRs may be located both synaptically
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FIGURE 4 | Comparison of kinetics and pharmacological properties of IPSCs mediated by α2β2γ2 and α4β2γ2 GABAARs. (A) Cumulative probability data
averaged from four cells expressing α4β2γ2 GABAARs were compared to previously published data for α2β2γ2 GABAARs (n = 7; Dixon et al., 2014). We found no
significant differences in IPSC amplitudes, 10–90% rise times or decay time constants. (B) Sample recordings of spontaneous IPSCs mediated by α4β2γ2
GABAARs before and after the application of 10 mM ethanol and 1 μM diazepam. (C) Examples of mean IPSC waveforms mediated by α4β2γ2 GABAARs, each
averaged from >100 events from a single cell, before and after the application of 10 mM ethanol or 1 μM diazepam. (D) The decay time constants of IPSCs
mediated by α4β2γ2 GABAARs were significantly prolonged by 10 mM ethanol but not by 1 μM diazepam (left). In contrast, IPSCs mediated by α2β2γ2 GABAARs
were significantly prolonged by 1 μM diazepam but not by 30 mM ethanol (right). Diazepam data for α2β2γ2 GABAARs were reproduced from (Dixon et al., 2014).
∗p < 0.05 relative to drug-free control in same cell.
and peri-synaptically in HEK293 cells by introducing mutations
that dramatically enhanced the glycine sensitivity. We reasoned
that if GlyRs are located peri-synaptically then enhancing their
glycine sensitivity may render them susceptible to activation by
synaptically released glycine, and if so this should be detectable
as an additional slow rise time component (Wu et al., 2012). As
noted above, α3P185L results from a post-transcriptional RNA
editing mechanism that is upregulated in (and is causative of)
human temporal lobe epilepsy (Eichler et al., 2008, 2009). This
mutation reduces the glycine EC50 from 70.9 to 7.4μM(Legendre
et al., 2009). We also investigated the α1A288G mutation (which is
not associated with a disease) because it reduces the glycine EC50
from 30.9 to 6.0 μM (Lynagh and Lynch, 2010).
As shown in Figures 2A–C, IPSCs mediated by α1A288Gβ
GlyRs exhibited signiﬁcantly slower rise times and decay time
constants, although additional slow components were never
observed on the rising phase of IPSCs. As with unmutated
α1β GlyRs, these properties were monotonically distributed
(Figure 2C) suggesting a single postsynaptic receptor population.
Similarly, Figures 3A–C shows that IPSCs mediated by α3P185Lβ
GlyRs also exhibited signiﬁcantly slower rise times and decay
time constants that were distributed monotonically. Thus, we
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were not able to unequivocally distinguish a putative peri-
synaptic GlyR population in either case.
GABAergic IPSCs
As with glycinergic IPSCs, we typically observed GABAergic
IPSCs in around 20% of HEK293 cells. The rise times and
decay time constants of IPSCs recorded from the dominant
(α1β2γ2) synaptic subtype (1.2 and 4.0 ms, respectively) are in
close accordance with those recorded from neurons known to
predominantly express this subtype (Dixon et al., 2014). The
co-culture system has revealed that other GABAAR subunit
combinations can yield IPSCs with dramatically diﬀerent rise and
decay times (Wu et al., 2012; Dixon et al., 2014), although it is
as yet unclear how these properties relate to those of the same
isoforms when expressed in native neuronal synapses.
We have previously demonstrated that the eﬀects of some
clinically important drugs on co-culture GABAergic synaptic
IPSCs are similar to those recorded at corresponding neuronal
synapses. For example, 1 μM diazepam or 0.1 μM ﬂunitrazepam
signiﬁcantly increased the decay time constants of IPSCs
mediated by α2-containing GABAARs (Dixon et al., 2014)
and 1 μM zolpidem or 1 μM eszopiclone increased IPSC
magnitudes and decay time constants of IPSCs mediated
by α1-containing GABAARs (Dixon et al., 2015). Here we
extended this characterisation by performing a ‘reciprocal’
pharmacological comparison of α2β2γ2 and α4β2γ2 GABAARs,
based the knowledge that α4-containing GABAARs are highly
sensitive to ethanol and insensitive to benzodiazepines, whereas
α2-containing GABAARs have the opposite proﬁle (Knoﬂach
et al., 1996; Wallner et al., 2006). As shown in Figures 4A,B,
IPSCs mediated by recombinant α2β2γ2 and α4β2γ2 GABAARs
exhibit identical amplitudes, 10–90% rise times and decay
time constants. A physiologically relevant (10 mM) ethanol
concentration signiﬁcantly increased the IPSC decay time
constant in α4β2γ2 GABAARs whereas 1 μM diazepam
had no eﬀect (Figures 4C,D). On the other hand, 1 μM
diazepam signiﬁcantly prolonged the IPSC decay time constant
in α2β2γ2 GABAARs (Dixon et al., 2014), whereas even
a very high (30 mM) ethanol concentration had no eﬀect
(Figure 4D).
DISCUSSION
Applications of the Protocol
We have described protocols for reliably generating recombinant
inhibitory synapses that incorporate deﬁned GlyR or GABAAR
isoforms of interest. These are suitable for investigating (1)
the kinetics of IPSCs mediated by deﬁned GABAAR or GlyR
isoforms, (2) the eﬀects of drugs on IPSCs mediated by deﬁned
GABAAR or GlyR isoforms, (3) the eﬀect of posttranslational
modiﬁcations (e.g., phosphorylation) and hereditary disease
mutations on the formation and function of both types
of synapses, and (4) synaptogenesis and synaptic clustering
mechanisms in both types of synapses. We now expand on each
of these points.
IPSC Kinetics
Inhibitory post-synaptic currents mediated by diﬀerent synaptic
GABAAR or GlyR isoforms exhibit unique physiological and
pharmacological proﬁles. It is useful to quantitate these
properties because they may help in identifying the presence,
or even the role, of a particular isoform in a particular
neuron and also because accurate parameters provide key
inputs into computational models of neuron or network
function. Although studying recombinant receptors in standard
heterologous expression systems such as HEK293 cells or
Xenopus oocytes allows the electrophysiological properties of
a single isoform to be studied in isolation, this approach is
limited because the neurotransmitter must be applied artiﬁcially
and it cannot mimic the fast (μs) dynamic neurotransmitter
concentration proﬁle that exists in the synaptic cleft.
Investigating Drug Efficacy and
Selectivity
The GABAAR is an established therapeutic target for clinical
indications including epilepsy, anxiolysis, muscle spasms,
sedation and anesthesia. GABAAR-targeted drugs currently in
clinical use are not strongly subtype-selective and this can lead
to dose-limiting side eﬀects. For example, diazepam produces
eﬀective anxiolysis by positively modulating α2-containing
GABAARs, although it also elicits the side eﬀect of sedation by
modulating α5-containing GABAARs (Trincavelli et al., 2012).
Drugs speciﬁc for other isoforms are also being sought. For
example, selective modulators of α5-containing GABAARs are
being developed for a range of indications including stroke,
cognitive impairment, and schizophrenia (Soh and Lynch,
2015). Although GlyRs are not currently targeted by clinically
useful drugs, molecules that selectively enhance α3-containing
GlyRs are considered promising as new generation treatments
for chronic pain (Zeilhofer, 2005; Lynch and Callister, 2006).
When evaluating new molecules as potential therapeutic lead
compounds for synaptically localized receptors, it is important to
test their potency, eﬃcacy and subtype-selectivity under realistic
synaptic activation conditions. The system we describe provides
the most deﬁnitive means available of evaluating drug eﬃcacy
and selectivity at IPSCs mediated by deﬁned receptor isoforms.
Investigating Disease Mutations
Engineered synapses have yet to be used to study disease-
causing GABAAR mutations or modiﬁcations, and hence, the
method has not realized its full potential as a model system
for understanding the molecular pathology of neurological
disorders. Mutations in GABAAR α1 and γ2 subunits have long
been associated with genetic epilepsy syndromes (Macdonald
et al., 2010). Thus far, the function and pharmacology of epilepsy-
causing mutant GABAARs have only been investigated using
whole-cell recordings of steady-state GABA-activated currents in
heterologous expression systems. The diﬀering approaches that
have been used to analyze the eﬀects of these mutations have lead
to controversy, particularly in the case of the γ2R43Q mutation
(Petrou and Reid, 2012). Moreover, of all the identiﬁed epilepsy-
causing mutant GABAARs that exhibit partial or full expression
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 December 2015 | Volume 8 | Article 80
Dixon et al. Generation of Recombinant Inhibitory Synapses
at the cell membrane, there is an animal knock-in model of
only one (Petrou and Reid, 2012). Transgenic animal models are
aﬄicted by compensatory mechanisms that can obfuscate data,
especially those involving ion channel genetic manipulations that
aﬀect GABAergic transmission (Harris et al., 2011). Because co-
culture α1β2γ2 GABAAR synapses successfully recapitulate the
kinetics of neuronal IPSCs (Dixon et al., 2014), they may provide
a promising means of investigating the synaptic signaling defects
induced by hereditary epilepsy mutations to α1 and γ2 subunits.
Glycinergic co-culture synapses incorporating α1D80Aβ and
α1A52Sβ GlyRs have been shown to exhibit accelerated IPSC decay
rates that strongly resemble those recorded in native synapses
from mutant mice homozygous for the same mutations (Zhang
et al., 2014). This suggests that the co-culture system should be
useful for modeling the eﬀects of hyperekplexia mutations to α1
and β subunits (Bode and Lynch, 2014) and autism mutations
to α2 subunits (Pilorge et al., 2015). Here we investigated the
eﬀect of the α3P185L mutation that is associated with temporal
lobe epilepsy. The mutation resulted in slowing of the IPSC decay
rate (Figure 3). However, glycinergic synapses are absent in the
temporal lobe and it is thought that the aﬀected receptors are
located presynaptically at glutamatergic synapses. In this case, our
results suggest the mutant GlyR would remain open for longer
during each synaptic event, thus potentiating an excitatory Cl
ﬂux leading to enhanced excitatory neurotransmission that could
underlie the disorder (Eichler et al., 2008, 2009; Legendre et al.,
2009).
Synaptogenesis and Synaptic Clustering
Mechanisms
Co-culture synapses have been used extensively to probe the roles
of synaptic adhesion molecules in the formation of glutamatergic
or GABAergic synapses (Scheiﬀele et al., 2000; Biederer et al.,
2002; Dean et al., 2003; Graf et al., 2004; Sara et al., 2005;
Kim et al., 2006; Dong et al., 2007; Fuchs et al., 2013) or to
investigate the impact of disease-causing neuroligin mutations
on GABAergic synaptogenesis (Chubykin et al., 2005; Sun et al.,
2011). The strengths and weaknesses of co-cultures in this respect
have recently been reviewed (Fuchs et al., 2013).
CONCLUSION
As the presynaptic terminals of our engineered synapses
are provided by real neurons, their function is likely to
resemble those of synapses in vivo. Indeed, serial electron
microscopic reconstructions of GABAergic terminals onto
HEK293 cells have conﬁrmed that their ultrastructures are similar
to those of native neurons (Fuchs et al., 2013). However, the
postsynaptic specializations are less likely to resemble those of
neurons given that HEK293 cells do not endogenously express
all necessary postsynaptic clustering proteins at appropriate
levels for synaptogenesis. In addition, some proteins that
they do express may lack neuron-speciﬁc post-translational
modiﬁcations required for correct synaptic function. These
factors could ultimately alter the geometry of the synaptic cleft
and the postsynaptic receptor clustering density, leading to
non-physiological changes in the neurotransmitter concentration
proﬁle that could aﬀect IPSC kinetics. This uncertainty is the
main limitation of the technique. We have addressed this as far
as possible by comparing the properties of engineered synapses
with those of real synapses in cases where we can be reasonably
sure about the synaptic subunit composition.
However, due to their non-physiological status, engineered
synapses also oﬀer opportunities to investigate new clustering
mechanisms. If, for example, substitution of a particular
pLGIC subunit results in a drastic, unexpected slowing of
the IPSC rise time, it is possible that synaptic receptors
have been de-clustered in a manner that may not occur in
a neuron. This could in turn lead to the identiﬁcation of
novel clustering molecules and mechanisms. HEK293 cells are
ideal for investigating such questions: they do not express all
proteins necessary for synaptogenesis, but they do provide a
high eﬃciency of transfection, faithful protein translation and
a small, electronically compact shape appropriate for accurate
quantitation of IPSC rise and decay times (Thomas and Smart,
2005).
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